The implantable cardioverter defibrillator (ICD) represented a breakthrough in the prevention of sudden cardiac death. In addition to its use in secondary prevention, the indication of ICD therapy in primary prevention is also being intensively researched. A study published last year evaluated the relevance of ICD implantation in the acute phase of acute myocarditis and a registry study investigated the benefits of a wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death in post-infarction patients.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- Internal thoracoscopy
Diagnostic indications
- Follow-up care for head and neck cancer
What is the significance of FDG PET-CT?
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- Systemic lupus erythematosus
Increased risk of pulmonary manifestations
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis
More DMARDs can reduce glucocorticoids in LORA
- Atopic dermatitis